Cargando…

Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones

Fluoroquinolones are associated with an increased risk of Clostridioides difficile infection (CDI). Probiotic supplementation has been shown to reduce the risk of antibiotic-associated diarrhea with variable effects on CDI. The objective of this study was to evaluate receipt of probiotics on develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheffield, Mary E., Jones, Bruce M., Terrell, Blake, Wagner, Jamie L., Bland, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396168/ https://www.ncbi.nlm.nih.gov/pubmed/34449745 http://dx.doi.org/10.3390/pharmacy9030141

Ejemplares similares

Reductions in Postdischarge Clostridioides difficile Infection after an Inpatient Health System Fluoroquinolone Stewardship
por: Ashley Jones, K., et al.
Publicado: (2021)

Consortium of Probiotics Attenuates Colonization of Clostridioides difficile
por: Li, Xianping, et al.
Publicado: (2019)

Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
por: Wren, Callyn Mariah, et al.
Publicado: (2022)

Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové
por: Vaverková, Kristýna, et al.
Publicado: (2021)

Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain
por: Skinner, Andrew M., et al.
Publicado: (2020)

Reductions in inpatient fluoroquinolone use and postdischarge Clostridioides difficile infection (CDI) from a systemwide antimicrobial stewardship intervention
por: Jones, K. Ashley, et al.
Publicado: (2021)

Impact of Reduced Fluoroquinolone Use on Clostridioides difficile Infections Resulting From the Fluoroquinolone-Resistant Ribotype 027 Strain in a Veterans Affairs Medical Center
por: Redmond, Sarah N., et al.
Publicado: (2019)

Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile
por: Dingle, Kate E., et al.
Publicado: (2023)

Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
por: Olaitan, Abiola O., et al.
Publicado: (2023)

Is Three Company or a Crowd? Comparing and Contrasting U.S. and European Clostridioides difficile Clinical Practice Guidelines
por: Jones, Jordan, et al.
Publicado: (2022)

Decreasing ICU-associated Clostridioides difficile infection through fluoroquinolone restriction, the FIRST trial: a study protocol
por: Safdar, Nasia, et al.
Publicado: (2021)

A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis
por: Shelby, Rita D., et al.
Publicado: (2020)

Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism
por: Koh, Elvin, et al.
Publicado: (2022)

Role of probiotics in preventing Clostridioides difficile infection in older adults: an integrative review
por: Barbosa, Maria Lucianny Lima, et al.
Publicado: (2023)

Personalized Clostridioides difficile engraftment risk prediction and probiotic therapy assessment in the human gut
por: Carr, Alex, et al.
Publicado: (2023)

Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors
por: Vasavada, Shaleen, et al.
Publicado: (2022)

Applications of Lactobacillus acidophilus-Fermented Mango Protected Clostridioides difficile Infection and Developed as an Innovative Probiotic Jam
por: Lee, Bao-Hong, et al.
Publicado: (2021)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea
por: McCusker, Margaret E., et al.
Publicado: (2003)

Is primary prevention of Clostridioides difficile infection possible with combination probiotics in elderly orthopedic patients?
por: NAGAMINE, Takahiko
Publicado: (2019)

In Vitro and In Vivo Anti-Clostridioides difficile Effect of a Probiotic Bacillus amyloliquefaciens Strain
por: Islam, Md Imtiazul, et al.
Publicado: (2022)

2387. Learning the Influence of Individual Clostridioides difficile Infections
por: Mu, Emily, et al.
Publicado: (2019)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Fluoroquinolone Resistance and Clostridium difficile, Germany
por: Zaiß, Nils Henning, et al.
Publicado: (2010)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Clostridioides difficile infection and One Health: an equine perspective
por: Hain‐Saunders, Natasza M.R., et al.
Publicado: (2022)

Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates
por: Pensinger, Daniel A., et al.
Publicado: (2023)

Uncovering the Harms of Treating Clostridioides difficile Colonization
por: Polage, Christopher R., et al.
Publicado: (2021)

Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
por: van Werkhoven, Cornelis H., et al.
Publicado: (2021)

Gut metabolites predict Clostridioides difficile recurrence
por: Dawkins, Jennifer J., et al.
Publicado: (2022)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Microbiota-based markers predictive of development of Clostridioides difficile infection
por: Berkell, Matilda, et al.
Publicado: (2021)

Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water
por: Gaisawat, Mohd Baasir, et al.
Publicado: (2022)

2339. Clostridioides difficile: Impact of Active Screening of Asymptomatic Carriers and Testing Stewardship
por: Beth Graham, Mary, et al.
Publicado: (2019)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_482iulisu8bvedrd39p9m29t7h